Trial: A Study of the Effectivensss and Safety of Topiramate for the Prevention of Migraine Attacks in Children.
Purpose: The primary purpose of this study is to evaluate the effectiveness and safety of topiramate compared with placebo in the prevention of migraine attacks in children (12 to 17 years of age).
Condition: Migraine, vascular headache
Drug: Topamax (topiramate)
Device:
Procedure:
Trial Phase: Phase III
Official Title: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Topiramate for the Prophylaxis of Migraine in Pediatric Subjects 12 to 17 Years of Age.
Locations: FL, GA, KY, MI, MO, NC, OH, PA, TX, VA
For more information: http://clinicaltrials.gov/show/NCT00210535
Related content: Topamax Profile
______________
Source:
ClinicalTrials.gov
